TY  - JOUR

T1  - Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.

JO  - Br J Cancer

UR  - http://eprints.whiterose.ac.uk/107826/

PY  - 2000/05/01

AU  - Dobson LS

AU  - Lorigan PC

AU  - Coleman RE

AU  - Hancock BW

ED  - 

DO  - DOI: 10.1054/bjoc.2000.1176

VL  - 82

IS  - 9

SP  - 1547

EP  - 1552

Y2  - 2025/10/10

ER  -